The Wayback Machine - https://web.archive.org/web/20160616104647/https://en.wikipedia.org/wiki/Lazabemide

Lazabemide

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Lazabemide
Lazabemide.png
Systematic (IUPAC) name
N-(2-aminoethyl)-5-chloro-pyridine-2-carboxamide
Clinical data
Routes of
administration
Oral
Legal status
Legal status
  • ℞ (Prescription only)
Identifiers
CAS Number 103878-84-8
ATC code none
PubChem CID 71307
IUPHAR/BPS 6640
ChemSpider 64426
UNII 420HD787N9 YesY
KEGG D04681
Chemical data
Formula C8H10ClN3O
Molar mass 199.64 g/mol

Lazabemide (proposed trade names Pakio, Tempium) is a reversible and selective inhibitor of monoamine oxidase B (MAO-B) that was under development as an antiparkinsonian agent but was never marketed.[1]

References[edit]

  1. ^ Henriot S, Kuhn C, Kettler R, Da Prada M (1994). "Lazabemide (Ro 19-6327), a reversible and highly sensitive MAO-B inhibitor: preclinical and clinical findings.". J Neural Transm Suppl. 41: 321–325. PMID 7931245. 


Navigation menu

Personal tools

Namespaces

Variants

More

Morty Proxy This is a proxified and sanitized view of the page, visit original site.